Gossot D, Debrosse D, Grunenwald D
Département de Chirurgie Thoracique, Institut Mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris.
Ann Dermatol Venereol. 2000 Dec;127(12):1065-7.
Endoscopic thoracic sympathectomy is accepted as the treatment of choice for palmar hyperhidrosis. But the interest and the results of endoscopic thoracic sympathectomy for isolated axillary hyperhidrosis are still discussed.
In a series of 435 patients operated on for hyperhidrosis of the upper limbs during the 5 past years, 23 were suffering from isolated axillary hyperhidrosis (5.2 p. 100). All patients had been previously treated by local agents and 3 had iontophoresis. All patients underwent a bilateral endoscopic thoracic sympathectomy that was performed in one stage. Sympathectomy was done according to the usual technique but was extended down to T5. All patients were then contacted by phone to answer a detailed questionnaire. Four patients were lost for follow-up. The mean follow-up of the 19 remaining patients was 26 months (ranging 3 to 41 months).
There was no intraoperative or postoperative complication. All patients were discharged the day after surgery. All but one (95 p. 100) were cured from their axillary hyperhidrosis. All of them experienced compensatory sweating (100 p. 100). This compensatory sweating was considered as mild by 8 patients, as embarrassing in 8 and as distressing in 3. Eleven patients complained of excessive dryness of the hands. This was considered as a minor adverse effect by 8 patients and as problematic by 3 patients. Finally, 16 patients were satisfied while 3 claimed they regretted having been operated on.
The rate of compensatory sweating and the rate of dissatisfaction are higher after endoscopic thoracic sympathectomy for axillary hyperhidrosis than after endoscopic thoracic sympathectomy for palmar hyperhidrosis. Endoscopic thoracic sympathectomy for axillary hyperhidrosis should be foreseen only when all other therapies have been attempted.
内镜下胸交感神经切断术被公认为是治疗手汗症的首选方法。但对于单纯性腋窝多汗症的内镜下胸交感神经切断术的关注度及疗效仍存在争议。
在过去5年中,435例因上肢多汗症接受手术的患者中,23例患有单纯性腋窝多汗症(占5.2%)。所有患者此前均接受过局部用药治疗,其中3例接受过离子导入治疗。所有患者均接受了一期双侧内镜下胸交感神经切断术。交感神经切断术采用常规技术,但范围扩大至T5。随后通过电话联系所有患者,让其填写一份详细问卷。4例患者失访。其余19例患者的平均随访时间为26个月(3至41个月)。
术中及术后均无并发症。所有患者术后次日出院。除1例(占95%)外,所有患者的腋窝多汗症均得到治愈。所有患者均出现代偿性出汗(占100%)。8例患者认为这种代偿性出汗较轻,8例认为令人尴尬,3例认为痛苦。11例患者抱怨手部过度干燥。8例患者认为这是轻微的不良反应,3例患者认为有问题。最后,16例患者表示满意,3例表示后悔接受手术。
内镜下胸交感神经切断术治疗腋窝多汗症后的代偿性出汗发生率和不满意率高于治疗手汗症。只有在尝试了所有其他治疗方法后,才应考虑内镜下胸交感神经切断术治疗腋窝多汗症。